Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 5 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Increased glucose availability sensitizes pancreatic cancer to chemotherapy.
Nat Commun. 2023 Jun 28;14(1):3823. doi: 10.1038/s41467-023-38921-8.
Nat Commun. 2023.
PMID: 37380658
Free PMC article.
Clinical development of IDH1 inhibitors for cancer therapy.
Zarei M, Hue JJ, Hajihassani O, Graor HJ, Katayama ES, Loftus AW, Bajor D, Rothermel LD, Vaziri-Gohar A, Winter JM.
Zarei M, et al. Among authors: graor hj.
Cancer Treat Rev. 2022 Feb;103:102334. doi: 10.1016/j.ctrv.2021.102334. Epub 2021 Dec 28.
Cancer Treat Rev. 2022.
PMID: 34974243
Review.
Item in Clipboard
Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors.
Vaziri-Gohar A, Cassel J, Mohammed FS, Zarei M, Hue JJ, Hajihassani O, Graor HJ, Srikanth YVV, Karim SA, Abbas A, Prendergast E, Chen V, Katayama ES, Dukleska K, Khokhar I, Andren A, Zhang L, Wu C, Erokwu B, Flask CA, Zarei M, Wang R, Rothermel LD, Romani AMP, Bowers J, Getts R, Tatsuoka C, Morton JP, Bederman I, Brunengraber H, Lyssiotis CA, Salvino JM, Brody JR, Winter JM.
Vaziri-Gohar A, et al. Among authors: graor hj.
Nat Cancer. 2022 Jul;3(7):852-865. doi: 10.1038/s43018-022-00393-y. Epub 2022 Jun 9.
Nat Cancer. 2022.
PMID: 35681100
Free PMC article.
Item in Clipboard
Wild-type IDH1 inhibition enhances chemotherapy response in melanoma.
Zarei M, Hajihassani O, Hue JJ, Graor HJ, Loftus AW, Rathore M, Vaziri-Gohar A, Asara JM, Winter JM, Rothermel LD.
Zarei M, et al. Among authors: graor hj.
J Exp Clin Cancer Res. 2022 Sep 24;41(1):283. doi: 10.1186/s13046-022-02489-w.
J Exp Clin Cancer Res. 2022.
PMID: 36153582
Free PMC article.
Item in Clipboard
Targeting wild-type IDH1 enhances chemosensitivity in pancreatic cancer.
Zarei M, Hajihassani O, Hue JJ, Graor HJ, Rothermel LD, Winter JM.
Zarei M, et al. Among authors: graor hj.
bioRxiv [Preprint]. 2023 Mar 29:2023.03.29.534596. doi: 10.1101/2023.03.29.534596.
bioRxiv. 2023.
PMID: 37034685
Free PMC article.
Preprint.
Item in Clipboard
IDO1 Is a Therapeutic Target for Pancreatic Cancer-Associated Depression.
Hue JJ, Graor HJ, Zarei M, Katayama ES, Ji K, Hajihassani O, Loftus AW, Vaziri-Gohar A, Winter JM.
Hue JJ, et al. Among authors: graor hj.
Mol Cancer Ther. 2022 Dec 2;21(12):1810-1822. doi: 10.1158/1535-7163.MCT-22-0055.
Mol Cancer Ther. 2022.
PMID: 36190971
Item in Clipboard
Prodromal depression and anxiety are associated with worse treatment compliance and survival among patients with pancreatic cancer.
Davis NE, Hue JJ, Kyasaram RK, Elshami M, Graor HJ, Zarei M, Ji K, Katayama ES, Hajihassani O, Loftus AW, Shanahan J, Vaziri-Gohar A, Rothermel LD, Winter JM.
Davis NE, et al. Among authors: graor hj.
Psychooncology. 2022 Aug;31(8):1390-1398. doi: 10.1002/pon.5945. Epub 2022 May 6.
Psychooncology. 2022.
PMID: 35470512
Item in Clipboard
Cite
Cite